Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

9822	Companies
197174	Keywords
128243	Articles
104861	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

BRIEF

published on 02/03/2026 at 07:05, 6 days 4 hours ago

Newron Pharmaceuticals met en avant les bienfaits de l'Evenamide pour la schizophrénie

Essais Cliniques Schizophrénie Newron Pharmaceuticals Evenamide Résistant Au Traitement
BRIEF

published on 02/03/2026 at 07:05, 6 days 4 hours ago

Newron Pharmaceuticals Highlights Benefits of Evenamide for Schizophrenia

Clinical Trials Schizophrenia Newron Pharmaceuticals Evenamide Treatment-resistant
PRESS RELEASE

published on 02/03/2026 at 07:00, 6 days 5 hours ago

Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia
Newron Pharmaceuticals S.p.A. announces publication highlighting Evenamide as adjunctive treatment in schizophrenia. Scientific evidence supports unique approach

Schizophrenia Publication Newron Pharmaceuticals Evenamide Adjunctive Treatment
BRIEF

published on 01/07/2026 at 07:05, 1 month 2 days ago

Début d'un essai clinique pour l'événamide au Japon

Newron Pharmaceuticals Evenamide Traitement De La Schizophrénie Essai De Phase III EA Pharma
BRIEF

published on 01/07/2026 at 07:05, 1 month 2 days ago

Clinical Trial for Evenamide in Japan Commences

Phase III Trial Newron Pharmaceuticals Evenamide Schizophrenia Treatment EA Pharma
PRESS RELEASE

published on 01/07/2026 at 07:00, 1 month 2 days ago

Newron Pharmaceuticals S.p.A.: EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
Newron Pharmaceuticals S.p.A. announces Phase III Clinical Trial initiation with Evenamide, a novel Schizophrenia treatment in Japan, led by EA Pharma, a subsidiary of Eisai

Schizophrenia Newron Pharmaceuticals Evenamide Phase III EA Pharma
BRIEF

published on 01/06/2026 at 07:05, 1 month 3 days ago

Newron Pharmaceuticals renforce son portefeuille de propriété intellectuelle pour Evenamide

Schizophrénie Brevet Newron Pharmaceuticals Evenamide Modulation Du Glutamate
BRIEF

published on 01/06/2026 at 07:05, 1 month 3 days ago

Newron Pharmaceuticals Strengthens IP Portfolio for Evenamide

Patent Schizophrenia Newron Pharmaceuticals Evenamide Glutamate Modulation
PRESS RELEASE

published on 01/06/2026 at 07:00, 1 month 3 days ago

Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent
Newron Pharmaceuticals obtains new EU Composition of Matter Patent EP4615820 for Evenamide, extending exclusivity into 2044

Patent Intellectual Property Schizophrenia Newron Pharmaceuticals Evenamide
BRIEF

published on 12/08/2025 at 07:05, 2 months 1 day ago

Newron Launches US Phase III Study on Evenamide for Schizophrenia

Clinical Trial Schizophrenia Newron Pharmaceuticals Evenamide Phase III Study

1 2 ... 9

Accesswire

Published on 02/09/2026 at 11:30, 31 minutes ago

FireFox Gold Expands the Northeast Zone, including 54.91 g/t Gold over 1.95 Metres in 95 Metre Step-out at Mustajärvi Gold Project, Finland
Published on 02/09/2026 at 08:02, 3 hours 59 minutes ago

Southern Energy Corp. Announces US$23.5 Million Financings and Royalty Sale
Published on 02/08/2026 at 21:00, 15 hours 1 minute ago

Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 2 days 11 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 2 days 12 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.

View all ACCESSWIRE

EQS Group

Published on 02/09/2026 at 11:45, 16 minutes ago

Ex-CBRE Paul Saville-King Appointed Group Chief Executive Officer at Unispace
Published on 02/09/2026 at 11:42, 18 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 02/09/2026 at 11:39, 22 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 02/09/2026 at 11:00, 1 hour 1 minute ago

Iute Group Reports Unaudited 12M 2025 Results on 19 February 2026 – Invitation to Earnings Webcast/Call on the Same Day
Published on 02/09/2026 at 10:53, 1 hour 8 minutes ago

Personnel matters: Inga Stein-Barthelmes appointed managing director of HOWOGE Wohnungsbaugesellschaft mbH

Les Echos

Published on 02/09/2026 at 10:40, 1 hour 20 minutes ago

Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 02/09/2026 at 08:30, 3 hours 31 minutes ago

THERMADOR GROUPE : Plan to separate the roles of chairman and chief executive officer
Published on 02/09/2026 at 08:30, 3 hours 31 minutes ago

THERMADOR GROUPE : Projet de séparation des mandats de président et directeur général
Published on 02/09/2026 at 08:00, 4 hours 1 minute ago

Eiffage renforce son expertise dans le secteur du froid industriel avec une prise de participation majoritaire dans l’entreprise française Quercy Réfrigération
Published on 02/09/2026 at 08:00, 4 hours 1 minute ago

Eiffage strengthen its expertise in the industrial refrigeration sector with the acquisition of a majority holding in the French company Quercy Réfrigération

View all LES ECHOS COMFI WIRE